Latest Maintenance Contracts News

Page 4 of 4
X2M Connect reports a challenging quarter with a 64% revenue drop due to exiting low-margin hardware sales but boosts gross margin and expands its footprint with new contracts in the Middle East and South Korea alongside launching an AI platform for renewables.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Fluence Corporation Limited reported a robust 64.5% revenue increase in Q1 2025, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams, while maintaining its full-year guidance.
Victor Sage
Victor Sage
30 Apr 2025
Monadelphous Group Ltd reported a robust first half of FY2025 with revenue climbing 4.2% to $1.051 billion and net profit after tax surging 41.3%, underpinned by a strong contract pipeline and operational improvements.
Victor Sage
Victor Sage
18 Feb 2025
Aurizon Holdings posted a 3% revenue increase to $2.02 billion for 1HFY2025 but saw EBITDA dip 4% to $814 million, reflecting operational headwinds across key segments. The company declared a 9.2 cents per share interim dividend, signaling cautious optimism despite margin pressures.
Victor Sage
Victor Sage
17 Feb 2025
Fluence Corporation delivered a standout Q4 2024 with revenue more than doubling prior quarters, overcoming project delays and market headwinds to set the stage for robust growth in 2025.
Victor Sage
Victor Sage
31 Jan 2025
Mach7 Technologies reports a robust Q2 FY25 with a 15.6% increase in Contracted Annual Recurring Revenue, reaffirming its FY25 growth guidance and initiating a $5 million share buy-back.
Ada Torres
Ada Torres
31 Jan 2025
Change Financial Limited reported a robust Q2 FY25 with revenue surging 53% year-on-year, driven by its expanding PaaS platform, while strategically exiting its loss-making US operations to sharpen focus on Australia and New Zealand.
Victor Sage
Victor Sage
30 Jan 2025
Clever Culture Systems Ltd has achieved a key cashflow break-even milestone in Q4 2024, driven by strong sales growth from major pharmaceutical clients including AstraZeneca and Bristol Myers Squibb. The company is also advancing its product line with a new APAS® Contact Plate capability set for mid-2025 launch.
Victor Sage
Victor Sage
30 Jan 2025